Therapeutic Psychedelics Toolkit
In this current phase of clinical psychedelic medicine, as we move toward FDA-approval of new protocols with MDMA and psilocybin, and build upon our growing experience with ketamine-assisted psychotherapy (KAP), the field is making its way toward a more refined practice. Springing from the first wave of clinical psychedelic research and, ideally, rooted in ancestral wisdom, practitioners and scientists are forging a new chapter in mental healthcare.
The Andrew Weil Center for Integrative Medicine (AWCIM) is committed to whole person integrative care. It is important to provide evidence-based educational information about new approaches to health and wellbeing. Our Therapeutic Psychedelics Toolkit is being offered free to the public for ease of accessing reputable information on the topic. Always consult with your healthcare provider before embarking on any treatment approach.
AWCIM also provides a CME credit in-depth course on therapeutic psychedelics as part of their online education offerings for those looking to go deeper into the history and science around this topic.
Launch the ToolkitThis integrative cancer care toolkit has been developed to help those recently diagnosed feel less overwhelmed, learn about approaches to support their treatment and overall wellbeing, and gain access to useful resources.
This educational toolkit is designed for anyone recently diagnosed with cancer, as well as those interested in living well during and after cancer. It offers guidance on working effectively with oncology providers and treatment teams, and navigating the complexities of cancer care.
The content includes evidence-based recommendations for lifestyle practices, emotional and spiritual wellness, complementary therapies, and minimizing environmental exposures. Additionally, it provides trusted resources from reputable organizations, offering patient education and practical tips to support an integrative approach to cancer care and long-term wellness.
Launch the Toolkit